Hydroxylated Tricyclic Compounds
    14.
    发明申请
    Hydroxylated Tricyclic Compounds 有权
    羟基化三环化合物

    公开(公告)号:US20130317114A1

    公开(公告)日:2013-11-28

    申请号:US13992587

    申请日:2011-12-09

    IPC分类号: C07C217/52

    CPC分类号: C07C217/52

    摘要: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.

    摘要翻译: 本发明提供通过共价连接水溶性低聚物进行化学修饰的小分子药物。 本发明化合物当通过多种施用途径中的任一种施用时,显示出与未附着于水溶性低聚物的小分子药物的特性不同的特征。

    OLIGOMER MODIFIED DIAROMATIC SUBSTITUTED COMPOUNDS
    15.
    发明申请
    OLIGOMER MODIFIED DIAROMATIC SUBSTITUTED COMPOUNDS 有权
    低分子修饰的二取代的化合物

    公开(公告)号:US20130040961A1

    公开(公告)日:2013-02-14

    申请号:US13580580

    申请日:2011-02-22

    CPC分类号: A61K31/496 A61K47/60

    摘要: Disclosed are compounds comprising diaromatic substituted compound residues, namely the anti-viral (anti-HIV) drug delavirdine, covalently attached via a linkage to water-soluble, non-peptidic oligomers, specifically to poly(ethylene glycol) PEG) oligomers. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over non-oligomer modified diaromatic substituted compounds.

    摘要翻译: 公开了包含二芳基取代的化合物残基的化合物,即通过连接至水溶性非肽寡聚物,特别是聚(乙二醇)PEG)低聚物共价连接的抗病毒(抗HIV)药物地拉夫定。 本发明的化合物当通过任何多种施用途径施用时,显示出优于非低聚物修饰的二芳基取代的化合物的优点。

    Hydroxylated tricyclic compounds
    17.
    发明授权
    Hydroxylated tricyclic compounds 有权
    羟基化三环化合物

    公开(公告)号:US09090535B2

    公开(公告)日:2015-07-28

    申请号:US13992587

    申请日:2011-12-09

    CPC分类号: C07C217/52

    摘要: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.

    摘要翻译: 本发明提供通过共价连接水溶性低聚物进行化学修饰的小分子药物。 本发明化合物当通过多种施用途径中的任一种施用时,显示出与未附着于水溶性低聚物的小分子药物的特性不同的特征。